ClinicalTrials.gov
ClinicalTrials.gov Menu

Parent-Adolescent Interactions and Adolescent Development (PAIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01572441
Recruitment Status : Active, not recruiting
First Posted : April 6, 2012
Last Update Posted : February 24, 2017
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Tara M. Chaplin, Ph.D., George Mason University

Brief Summary:
The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.

Condition or disease
Substance Abuse

Detailed Description:
The study examines parenting behaviors and adolescent emotional responses during parent-adolescent interactions and whether these predict youth's current and future substance use over a 3 year follow-up.

Study Type : Observational
Estimated Enrollment : 250 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.
Study Start Date : September 2009
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Reactions
U.S. FDA Resources

Group/Cohort
12-14 year olds
No intervention administered. This is a longitudinal observational study including observation of behaviors and physiological responses.



Primary Outcome Measures :
  1. Substance Use [ Time Frame: Baseline ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  2. Substance Use [ Time Frame: 6 month follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  3. Substance Use [ Time Frame: 1 year follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  4. Substance Use [ Time Frame: 2 year follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  5. Substance Use [ Time Frame: 3 year follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.


Biospecimen Retention:   Samples With DNA
Retain saliva sample.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
12-14 year olds and their primary caregivers.
Criteria

Inclusion Criteria:

  • Adolescent between ages 12-14 years

Exclusion Criteria:

  • For adolescent, Intelligence Quotient (IQ) < 70 on standardized test, for parent, evidence of inability to read or write.
  • Evidence of a psychotic disorder for parent or adolescent
  • Diagnosis of autism or pervasive developmental disorder for adolescent, as determined by parent report in the screening.
  • For adolescent, current need for acute treatment of a psychiatric disorder, as determined by parent report in the study screening.
  • For adolescent and parent, inadequate English proficiency to comprehend task instructions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01572441


Locations
United States, Connecticut
Yale Stress Center
New Haven, Connecticut, United States, 06520
United States, Virginia
George Mason University
Fairfax, Virginia, United States, 22030
Sponsors and Collaborators
George Mason University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Tara Chaplin, Ph.D. Yale University

Publications of Results:
Other Publications:
Responsible Party: Tara M. Chaplin, Ph.D., Assistant Professor of Psychology, George Mason University
ClinicalTrials.gov Identifier: NCT01572441     History of Changes
Other Study ID Numbers: 0909005677
R01DA033431 ( U.S. NIH Grant/Contract )
First Posted: April 6, 2012    Key Record Dates
Last Update Posted: February 24, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: We will make data from the proposed laboratory study available to other researchers, after de-identifying study data and after publishing the main manuscripts on the study.

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders